Cannabis Business Times' Best Cannabis Companies to Work For - 2027 Is Accepting Entries! Enter now.
Cannabis Business Times' Best Cannabis Companies to Work For - 2027 Is Accepting Entries! Enter now.
Helpful, or Yet Another Hurdle? | Cannabis Business Times
Continue to Site »
Site will load in 15 seconds

Helpful, or Yet Another Hurdle?

Many industry experts agree President Joe Biden’s three-step cannabis reform plan was historic and removing the plant from the list of Controlled Substances would be ideal. But a rescheduling could make things more complex—or even a 'disaster'—for state-legal markets.

Kris
Michelle Simakis
December 23, 2022

Cannabis Business Times Editor Theresa Bennett, Senior Editor Zach Mentz, Associate Editor Andriana Ruscitto, and Managing Editor Patrick Williams contributed to this report, which was originally published online Oct. 26, 2022. Read the original, extended version here. 

Log in to view the full article
Recommended
8th Annual ‘Best Cannabis Companies to Work For’ Now Open for Entries
Sponsored
8th Annual ‘Best Cannabis Companies to Work For’ Now Open for Entries
Caoa 2026 Graphic
17 Senate Democrats File Bill to Federally Legalize Cannabis
Wyo 92293510
Wyoming Rejects Trump Administration’s Schedule III Cannabis Listing; Keeps It Schedule I
Mj Doj 357400065
Cannabis Prohibition Interests Don’t ‘Systemically Align’ With American Public, DOJ Says
Related Stories
Cannabis Plants Adobe Stock Credit The Allery Resized
What’s Next for the Cannabis Industry Following the Midterm Elections?
Sessions Woodfinmergedleaf
Texas Congressman Compares ‘In It To Make Money’ Cannabis Industry to Slavery; Alabama Mayor Takes Issue
Hearingmerged
Witnesses Stress Need For Cannabis Descheduling, Uniform Regulation at US House Hearing on Federal Reform
Us Capitol Stock Cbt
Global Alliance for Cannabis Commerce Discusses Federal and State Cannabis Policy Ahead of Congressional Hearing Testimony
More in Cannabis Rescheduling
Anti-Rescheduling Groups Attempting to Stay Schedule III Order Call Government’s Response ‘Meritless’
A drug testing group and pharmaceutical company asked a federal court to stay the order, claiming the DOJ has no defense other than diversions.
Ndasa mjj Stay 1877226248
17 Senate Democrats File Bill to Federally Legalize Cannabis
The Cannabis Administration and Opportunity Act would deschedule cannabis, removing it from the Controlled Substances Act.
Caoa 2026 Graphic
Wyoming Rejects Trump Administration’s Schedule III Cannabis Listing; Keeps It Schedule I
Wyoming Attorney General Keith G. Kautz announced that he won’t loosen restrictions on cannabis after there was little public interest in doing so.
Wyo 92293510
Cannabis Prohibition Interests Don’t ‘Systemically Align’ With American Public, DOJ Says
The Department of Justice argued that anti-rescheduling groups attempting to stay a Schedule III order have ‘pocketbook interests’ in prohibition.
Mj Doj 357400065
‘DEA Comes Out Swinging in Cannabis Rescheduling Hearing' Leads CBT’s Top Stories in June
CBT provided an in-the-courtroom analysis of the DEA’s first witness’s testimony in support of the Schedule III proposed rule.
Top Stories June 2026 Top Story Image Use
Prohibitionists Punch Back at Cannabis Rescheduling Hearing
Anti-rescheduling participants who oppose the Schedule III proposal attempt to expose flaws in a scientific and medical evaluation and discredit DEA witnesses.
Mj2 231724961
DEA Comes Out Swinging in Cannabis Rescheduling Hearing
The government argued in support of currently accepted medical use; anti-rescheduling parties attempted to poke holes in the Schedule III recommendation.
Activists representing Students for Sensible Drug Policy hold a press conference outside the Drug Enforcement Administration's headquarters ahead of the administrative law judge hearing for the Schedule III proposed cannabis rule on June 29 in Arlington, Va.
DEA Plans to Call Pain Management Doctor, FDA Official to Testify at Cannabis Reschedule Hearing
The Drug Enforcement Administration filed a prehearing statement summarizing its two proposed witnesses’ testimony.
Dea Statement Editorial Use Only
DEA Judge Sets Cannabis Hearing Schedule, Won’t Consider More Participants
The administrative law judge declined to consider pleas from non-parties to participate in the rescheduling hearing for the proposed Schedule III rule.
Canna hearing 1823580704
Should DEA’s One-Sided Cannabis Rescheduling Hearing Be Reason for Concern?
The government may lack a sufficient administrative record to defend a Schedule III decision in judicial review without any pro-rescheduling participants.
Us canna 618414605
DEA Names 7 Anti-Rescheduling Parties for Cannabis Hearing, Zero Pro Parties
Derek C. Julius will be the DEA’s chief administrative law judge to oversee the hearing of a proposed rule to reclassify cannabis as a Schedule III drug.
Dea 352810348
Feds Haven’t Provided ‘Clear Guidance, Feedback’ to Ohio on Cannabis Rescheduling
The state’s Division of Cannabis Control ‘doesn’t have a lot of great answers’ for its dual-licensed operators, the department’s legal counsel says.
Ohio 158935902 Flags
Page 1 of 19
Next Page